Abvion is an early-stage biotechnology company committed to pioneering antibody therapeutics rooted in the superior power of the natural immune response.
With our unique technology, we capture the essence of what makes a strong immune response. We perform serological antibody discovery with unprecedented molecular detail, enabling us to identify exceptional antibodies that provide superior protection against diseases. We use these antibodies to redefine standards of care, improve patient lives, and inspire a healthier tomorrow.
For more information, please visit Abvion.bio or email us at contact@abvion.bio.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Padualaan 8, Utrecht,3584 Ch,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://abvion.bio
- HQ
- Utrecht
Abvion Questions
Abvion's website is https://abvion.bio
Abvion's LinkedIn profile is https://nl.linkedin.com/company/abvion
Abvion has
3 employees.
View email and phone details for 3
employees at Abvion.
Abvion's industry is
Biotechnology Research
Abvion's top competitors are
Scellgen,
Byondis,
Cleara Biotech B.v.,
Lumox,
Qvq Holding Bv,
Abbvie,
Redgrasp Microlearning,
Genmab,
Cryocloud,
Cart-Tech B.v..
Abvion's categories are Biotechnology Research
Abvion's founding year is 2024
